Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (61-70 of 426) with videos related to

Pageof 43
Sort By:
Plos One|August 20, 2015
A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control InterventionsSabine Hermans, C Robert Horsburgh, Robin Wood
Royal Society Open Science|February 8, 2018
Environmental and social factors impacting on epidemic and endemic tuberculosis: a modelling analysisChacha M Issarow, Nicola Mulder, Robin Wood
Clinics in Chest Medicine|November 21, 2009
Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settingsStephen D Lawn, Katharina Kranzer, Robin Wood
Current Opinion in Infectious Diseases|December 15, 2010
Optimum time to start antiretroviral therapy during HIV-associated opportunistic infectionsStephen D Lawn, M Estée Török, Robin Wood
Clinical & Developmental Immunology|October 12, 2010
Changing concepts of "latent tuberculosis infection" in patients living with HIV infectionStephen D Lawn, Robin Wood, Robert J Wilkinson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 16, 2002
Exploring the costs of a limited public sector antiretroviral treatment programme in South AfricaAndrew Boulle, Christopher Kenyon, Jolene Skordis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2012
Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impactStephen D Lawn, Andrew D Kerkhoff, Robin Wood
AIDS (London, England)|October 25, 2011
Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individualsStephen D Lawn, Andrew D Kerkhoff, Robin Wood
AIDS (London, England)|July 2, 2005
How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis controlStephen D Lawn, Linda-Gail Bekker, Robin Wood
AIDS (London, England)|February 25, 2011
Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?Andrew D Kerkhoff, Robin Wood, Stephen D Lawn
Pageof 43

Showing results (61-70 of 426) with videos related to

Sort By:
Pageof 43
Plos One|August 20, 2015
A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control InterventionsSabine Hermans, C Robert Horsburgh, Robin Wood
Royal Society Open Science|February 8, 2018
Environmental and social factors impacting on epidemic and endemic tuberculosis: a modelling analysisChacha M Issarow, Nicola Mulder, Robin Wood
Clinics in Chest Medicine|November 21, 2009
Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settingsStephen D Lawn, Katharina Kranzer, Robin Wood
Current Opinion in Infectious Diseases|December 15, 2010
Optimum time to start antiretroviral therapy during HIV-associated opportunistic infectionsStephen D Lawn, M Estée Török, Robin Wood
Clinical & Developmental Immunology|October 12, 2010
Changing concepts of "latent tuberculosis infection" in patients living with HIV infectionStephen D Lawn, Robin Wood, Robert J Wilkinson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 16, 2002
Exploring the costs of a limited public sector antiretroviral treatment programme in South AfricaAndrew Boulle, Christopher Kenyon, Jolene Skordis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2012
Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impactStephen D Lawn, Andrew D Kerkhoff, Robin Wood
AIDS (London, England)|October 25, 2011
Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individualsStephen D Lawn, Andrew D Kerkhoff, Robin Wood
AIDS (London, England)|July 2, 2005
How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis controlStephen D Lawn, Linda-Gail Bekker, Robin Wood
AIDS (London, England)|February 25, 2011
Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?Andrew D Kerkhoff, Robin Wood, Stephen D Lawn
Pageof 43